CNBC Top NewsCodex · 实盘可交易 · 做多市场:美股▼ 亏 -3.99% · 已结算把握 6/10
北京时间·🕒 发布 17:56:50时区推断·⟳ 抓取 18:02:45·⚡ 决策 07-16 18:38:32 +35m47s·103.0 天前
联合健康二季度盈利大超预期并上调全年调整后EPS指引
联合健康二季度调整后EPS为6.38美元,高于市场预期4.90美元,收入1120.3亿美元也高于预期。
📄 原文CNBC Top News↗ 原文
UnitedHealth Group (UNH) earnings Q2 2026 Skip Navigation Markets Pre-Markets U.S. Markets Europe Markets China Markets…
▼ 亏 -3.99%入场 07-16 盘前首笔 @443.00 → 离场 07-17 常规开盘 @426.72
日 K 取自复盘打分切片 · 蓝点/蓝虚线 = 纸面入场价 · 灰虚线 = 纸面离场 · 持有期红底 = 赚(价格在入场线上方)、绿底 = 亏
💡 交易逻辑业绩和指引超预期,低于+4%回补
怎么买 限价买入 不高于 442.2、仅下一个交易日,不成交作废
怎么卖 止盈 +4%(半仓)/+8%(清仓) · 止损 -4% · 时间止损 3日
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
分时走势
做多 UNH.US 联合健康
建仓日早于近 30 天,只有日线图
成交明细 · 纸面
做多 UNH.US 联合健康
| 收益状态 | -3.99% 已平仓 |
|---|---|
| 进场成交 | 2026-07-16 · 盘前首笔 · 07-16 18:00 北京 · @443 |
| 离场成交 | 2026-07-17 · 常规开盘 · @426.72 |
| 毛收益 | -3.67% |
| 成本 | +0.32% |
| 净收益 | -3.99% |
| 计入收益 | -3.99% |
| 计入 | 同日重复,不计入曲线 |
| 建仓日 | 2026-07-16 · 进场不早于新闻时刻 + 2 分钟 |
| 契约提示 | LIMIT_AND_CHASE |
收益口径 event_time_plus_2min_10min_walk_open_topup_to_next_open_exchange_calendar_fill_model_local_notional_v9 · method_id m8db1cbc8f2d · 截至 2026-10-27 17:46
研究档案
🔎 新鲜度:最早出现 2026-07-16 · 扩散 medium · price-in 风险 medium ↗
消息传播链
- CNBC披露联合健康二季度EPS、收入均超预期,并上调全年调整后EPS指引。市场反应:CNBC文中称UNH盘前交易上涨约7%。
- 2026-07-16 06:32 UTC市场反应Futu非一手行情工具返回UNH.US最新常规价418.52美元、前收425.19美元;盘前实时跳涨未被该字段完整反映,因此以限价控制开盘追高。市场反应:近20日仅+1.82%,事件前没有明显连续抢跑。
关键理由
- 联合健康二季度调整后EPS为6.38美元,高于市场预期4.90美元,收入1120.3亿美元也高于预期。
- 公司将2026年调整后EPS指引从此前高于18.25美元上调至19.50-20.00美元,说明成本控制和重组改善已经进入利润表。
- 医疗成本率86.7%显著好于市场预期88.5%,对过去两年压制估值的医疗成本问题构成正向修复。
主要风险
- CNBC称盘前一度上涨约7%,若开盘直接大幅跳空,短线超预期可能已被一次性定价,限价未成交则放弃。
- 公司仍面临司法部Medicare计费调查,且CFO明确称医疗成本仍高于历史水平,反转还不是行业成本趋势完全正常化。
反向证据
- 做多前查反向 · 来源 kb_search · 日期 2026-07-16 · 影响 none
内部KB未命中UNH本次业绩的有效旧闻或相反纪要,未发现足以否定业绩超预期方向的反证。
检索:UnitedHealth Q2 2026 earnings guidance DOJ investigation medical cost ratio - 做多前查反向 · 来源 web · 日期 2026-07-16 · 影响 weakens
报道确认司法部Medicare计费调查仍在且医疗成本仍高于历史水平,削弱估值修复斜率但不否定本次业绩超预期。
检索:CNBC UnitedHealth Q2 2026 DOJ investigation medical costs 原文 ↗
历史先例(按相似度)
- CI 2024-05-02 Cigna Q1 2024 earnings beat and raised 2024 adjusted EPS guidance to at least $28.40; limited Medicare exposure reduced 原文 ↗
事件后 +1日 -0.9% · +3日 +0.6% · +5日 +1.9% - HUM 2025-07-30 Humana Q2 2025 adjusted EPS $6.27 and raised FY 2025 adjusted EPS/revenue guidance, with benefit ratio roughly in line a 原文 ↗
事件后 +1日 -4.4% · +3日 -5.4% · +5日 -1.9% - MOH 2024-07-24 Molina Q2 2024 adjusted EPS $5.86 and reaffirmed FY 2024 earnings guidance; Medicaid/Marketplace managed-care同机制但不是上调。 原文 ↗
事件后 +1日 +12.3% · +3日 +15.3% · +5日 +18.2% - CNC 2024-07-26 Centene Q2 2024 adjusted EPS $2.42同比增长15%, reaffirmed 2024 adjusted EPS floor above $6.80; Medicaid/Marketplace managed- 原文 ↗
事件后 +1日 +0.5% · +3日 +5.2% · +5日 +6.8% - OSCR 2024-08-07 Oscar Health Q2 2024 results raised full-year revenue and adjusted EBITDA outlook; 小市值医保平台同机制、弹性更高。 原文 ↗
事件后 +1日 +10.6% · +3日 +7.7% · +5日 +9.0% - CVS 2025-07-31 CVS Q2 2025 raised adjusted EPS guidance as Aetna health benefits performance improved; 规模接近UNH但混合药房/PBM业务。 原文 ↗
事件后 +1日 +0.6% · +3日 +2.1% · +5日 +2.4% - 1299 2024-08-22 AIA 2024H1 record new business profit/earnings growth and announced 2023-2026 OPAT per share CAGR target 9%-11%。 原文 ↗
事件后 +1日 +0.1% · +3日 +2.4% · +5日 +2.5% - 2318 2025-03-20 Ping An 2024全年营收+10.6%、净利+47.8%、现金分红提升5%, 保险同品类大市值盈利恢复。 原文 ↗
事件后 +1日 -3.5% · +3日 -5.1% · +5日 -4.7% - 2378 2025-03-19 Prudential plc 2024全年新业务利润按实质汇率增长、调整后经营利润/分红提升并加速回购。 原文 ↗
事件后 +1日 +0.4% · +3日 +4.2% · +5日 +7.0% - 601318 2024-10-21 Ping An 2024Q3 EPS显著高于预期, 同品类保险大市值盈利超预期但非医保。 原文 ↗
事件后 +1日 +0.3% · +3日 +2.1% · +5日 +1.1%
工具调用 · 历史记录,结果未知(4 种)
- stock_quote · 结果未知
- kb_search · 结果未知
- search_case_library · 结果未知
- validate_order · 结果未知
原文全文
展开原文 · 7,673 字
UnitedHealth Group (UNH) earnings Q2 2026
Skip Navigation
Markets
Pre-Markets
U.S. Markets
Europe Markets
China Markets
Asia Markets
World Markets
Currencies
Prediction Markets
Cryptocurrency
Futures & Commodities
Bonds
Funds & ETFs
Business
Economy
Finance
Health & Science
Media
Real Estate
Energy
Climate
Transportation
Investigations
Industrials
Retail
Wealth
Sports
Life
Small Business
Investing
Personal Finance
Fintech
Financial Advisors
Options Action
ETF Street
Buffett Archive
Earnings
Trader Talk
Tech
Cybersecurity
AI
Enterprise
Internet
Mobile
Social Media
CNBC Disruptor 50
Tech Guide
Politics
White House
Policy
Defense
Congress
Expanding Opportunity
Europe Politics
China Politics
Asia Politics
World Politics
Video
Latest Video
Full Episodes
Livestream
Top Video
Live Audio
Europe TV
Asia TV
CNBC Podcasts
CEO Interviews
Digital Originals
Watchlist
Investing Club
Trust Portfolio
Analysis
Trade Alerts
Meeting Videos
Homestretch
Jim's Columns
Education
Subscribe
PRO
Pro News
Josh Brown
Mike Santoli
Calls of the Day
My Portfolio
Stock Screener
Market Forecast
Options Investing
Chart Investing
Menu
Make It
select
USA
INTL
Search quotes, news & videos
SIGN IN
Create free account
Health and Science
UnitedHealth blows past estimates, hikes earnings outlook as it reins in costs
Published Thu, Jul 16 2026
5:56 AM EDT
Updated 24 Min Ago
Annika Kim Constantino
@annikakimc
WATCH LIVE
Key Points
UnitedHealth Group posted second-quarter earnings that blew past estimates and raised its full-year profit outlook, as the company better handles high medical costs and uses AI to help streamline operations.
The nation's largest private insurer said it expects 2026 adjusted earnings of $19.50 to $20 per share, up from a previous outlook of more than $18.25 per share.
The healthcare giant is working to stabilize margins by shrinking membership, exiting unprofitable contracts and pouring $1.5 billion into artificial intelligence to streamline operations.
In this article
UNH
Follow your favorite stocks
CREATE FREE ACCOUNT
UnitedHealth Group signage on the floor of the New York Stock Exchange on April 21, 2025.
Michael Nagle | Bloomberg | Getty Images
UnitedHealth Group
on Thursday posted second-quarter earnings that blew past estimates and raised its full-year profit outlook, as the company better manages high medical costs and uses AI to help streamline operations.
The largest private insurer in the U.S. said it expects 2026 adjusted earnings of $19.50 to $20 per share, up from a previous outlook of more than $18.25 per share. UnitedHealth is maintaining its full-year revenue guidance of greater than $439 billion. But CFO Wayne DeVeydt said in an interview that he expects the company to "do better than that" given the second-quarter beat.
Still, he said medical costs in the quarter remained "elevated over historical levels" – an issue that has dogged the broader insurance industry for more than two years.
"These results are not a reflection of trend bending or coming under control, but rather our efforts to start pushing down what is already an elevated number," DeVeydt said.
Here's what the company reported for the second quarter compared with what Wall Street was expecting, based on a survey of analysts by LSEG:
Earnings per share:
$6.38 adjusted vs. $4.90 expected
Revenue:
$112.03 billion vs. $110.85 billion expected
The company's stock jumped about 7% in premarket trading.
UnitedHealth's turnaround plan is gaining momentum following restructuring and an executive shuffle designed to counter challenges in the industry. The healthcare giant is working to stabilize margins by shrinking membership, exiting unprofitable contracts and pouring $1.5 billion into artificial intelligence to streamline operations.
DeVeydt said the company is using AI to improve both efficiency and patient care. For example, AI is helping speed up processes like prior authorizations and improve payment accuracy by detecting potential fraud, waste and abuse. That can help lower costs while improving patient care.
AI tools are not determining whether care is approved or denied, he said.
"I would say the turnaround, and I would emphasize that on our culture, it's really happening … that turnaround is translating to strong, strong earnings," DeVeydt told reporters. "So it shows that when we can do things the way we think they should be done, that we can be both a solution and be profitable."
But he emphasized that the turnaround is a "multi-year journey."
The company posted second-quarter net income of $5.48 billion, or $6.04 per share, compared with $3.41 billion, or $3.74 per share, in the same period a year ago. Excluding items like business divestitures, restructuring and the expected reduction of reserves for unprofitable contracts, UnitedHealth earned $6.38 per share.
Revenue climbed to $112.03 billion from $111.62 billion in the prior-year quarter. The company's insurer, UnitedHealthcare, and its Optum health-care unit both topped analysts' sales estimates for the quarter, according to StreetAccount.
UnitedHealth said rising healthcare costs are forcing insurers to raise premiums and adjust benefits, which is contributing to membership losses in both ACA exchange plans and privately run Medicare Advantage plans. The company said revenue has remained stable because higher pricing is offsetting the decline in enrollment.
But DeVeydt said that dynamic "is not a good thing for the system long term."
UnitedHealthcare served 48.5 million people in the second quarter, down 525,000 from the previous quarter. DeVeydt attributed membership declines largely to affordability pressures driven by higher healthcare costs, forecasting a loss of roughly 500,000 ACA exchange members and 1.1 million Medicare Advantage members in 2026.
Insurers, particularly those that run Medicare Advantage plans, have been pinched by an influx of people seeking care they delayed post-pandemic and high-cost specialty drugs like GLP-1s, among other factors.
But UnitedHealth's medical benefit ratio — a measure of total medical expenses paid relative to premiums collected — came in at 86.7% for the second quarter. That's an improvement from the 89.4% reported in the year-earlier period. A lower ratio typically indicates that the company collected more in premiums than it paid out in benefits, resulting in higher profitability.
Analysts were expecting a ratio of 88.5% for the quarter, according to StreetAccount.
The results come about a year after UnitedHealth
revealed
it is facing Department of Justice investigations over its Medicare billing practices.
DeVeydt said the company has no updates but continues to be "supportive" of the probe.
Choose CNBC as your preferred source on Google and never miss a moment from the most trusted name in business news.
Subscribe to CNBC PRO
Subscribe to Investing Club
Licensing & Reprints
CNBC Councils
Join the CNBC Panel
Digital Products
News Releases
Closed Captioning
Corrections
About CNBC
Internships
Site Map
Careers
Help
Contact
News Tips
Got a confidential news tip? We want to hear from you.
Get In Touch
CNBC Newsletters
Sign up for free newsletters and get more CNBC delivered to your inbox
Sign Up Now
Get this delivered to your inbox, and more info about our products and services.
Advertise With Us
Please Contact Us
Ad Choices
Privacy Policy
Your Privacy Choices
CA Notice
Terms of Service
©
2026
Versant Media, LLC. All Rights Reserved. A Versant Media Company.
Data is a real-time snapshot *Data is delayed at least 15 minutes.
Global Business and Financial News, Stock Quotes, and Market Data
and Analysis.
Market Data Terms of Use and Disclaimers
Data also provided by
Skip Navigation
Markets
Pre-Markets
U.S. Markets
Europe Markets
China Markets
Asia Markets
World Markets
Currencies
Prediction Markets
Cryptocurrency
Futures & Commodities
Bonds
Funds & ETFs
Business
Economy
Finance
Health & Science
Media
Real Estate
Energy
Climate
Transportation
Investigations
Industrials
Retail
Wealth
Sports
Life
Small Business
Investing
Personal Finance
Fintech
Financial Advisors
Options Action
ETF Street
Buffett Archive
Earnings
Trader Talk
Tech
Cybersecurity
AI
Enterprise
Internet
Mobile
Social Media
CNBC Disruptor 50
Tech Guide
Politics
White House
Policy
Defense
Congress
Expanding Opportunity
Europe Politics
China Politics
Asia Politics
World Politics
Video
Latest Video
Full Episodes
Livestream
Top Video
Live Audio
Europe TV
Asia TV
CNBC Podcasts
CEO Interviews
Digital Originals
Watchlist
Investing Club
Trust Portfolio
Analysis
Trade Alerts
Meeting Videos
Homestretch
Jim's Columns
Education
Subscribe
PRO
Pro News
Josh Brown
Mike Santoli
Calls of the Day
My Portfolio
Stock Screener
Market Forecast
Options Investing
Chart Investing
Menu
Make It
select
USA
INTL
Search quotes, news & videos
SIGN IN
Create free account
Health and Science
UnitedHealth blows past estimates, hikes earnings outlook as it reins in costs
Published Thu, Jul 16 2026
5:56 AM EDT
Updated 24 Min Ago
Annika Kim Constantino
@annikakimc
WATCH LIVE
Key Points
UnitedHealth Group posted second-quarter earnings that blew past estimates and raised its full-year profit outlook, as the company better handles high medical costs and uses AI to help streamline operations.
The nation's largest private insurer said it expects 2026 adjusted earnings of $19.50 to $20 per share, up from a previous outlook of more than $18.25 per share.
The healthcare giant is working to stabilize margins by shrinking membership, exiting unprofitable contracts and pouring $1.5 billion into artificial intelligence to streamline operations.
In this article
UNH
Follow your favorite stocks
CREATE FREE ACCOUNT
UnitedHealth Group signage on the floor of the New York Stock Exchange on April 21, 2025.
Michael Nagle | Bloomberg | Getty Images
UnitedHealth Group
on Thursday posted second-quarter earnings that blew past estimates and raised its full-year profit outlook, as the company better manages high medical costs and uses AI to help streamline operations.
The largest private insurer in the U.S. said it expects 2026 adjusted earnings of $19.50 to $20 per share, up from a previous outlook of more than $18.25 per share. UnitedHealth is maintaining its full-year revenue guidance of greater than $439 billion. But CFO Wayne DeVeydt said in an interview that he expects the company to "do better than that" given the second-quarter beat.
Still, he said medical costs in the quarter remained "elevated over historical levels" – an issue that has dogged the broader insurance industry for more than two years.
"These results are not a reflection of trend bending or coming under control, but rather our efforts to start pushing down what is already an elevated number," DeVeydt said.
Here's what the company reported for the second quarter compared with what Wall Street was expecting, based on a survey of analysts by LSEG:
Earnings per share:
$6.38 adjusted vs. $4.90 expected
Revenue:
$112.03 billion vs. $110.85 billion expected
The company's stock jumped about 7% in premarket trading.
UnitedHealth's turnaround plan is gaining momentum following restructuring and an executive shuffle designed to counter challenges in the industry. The healthcare giant is working to stabilize margins by shrinking membership, exiting unprofitable contracts and pouring $1.5 billion into artificial intelligence to streamline operations.
DeVeydt said the company is using AI to improve both efficiency and patient care. For example, AI is helping speed up processes like prior authorizations and improve payment accuracy by detecting potential fraud, waste and abuse. That can help lower costs while improving patient care.
AI tools are not determining whether care is approved or denied, he said.
"I would say the turnaround, and I would emphasize that on our culture, it's really happening … that turnaround is translating to strong, strong earnings," DeVeydt told reporters. "So it shows that when we can do things the way we think they should be done, that we can be both a solution and be profitable."
But he emphasized that the turnaround is a "multi-year journey."
The company posted second-quarter net income of $5.48 billion, or $6.04 per share, compared with $3.41 billion, or $3.74 per share, in the same period a year ago. Excluding items like business divestitures, restructuring and the expected reduction of reserves for unprofitable contracts, UnitedHealth earned $6.38 per share.
Revenue climbed to $112.03 billion from $111.62 billion in the prior-year quarter. The company's insurer, UnitedHealthcare, and its Optum health-care unit both topped analysts' sales estimates for the quarter, according to StreetAccount.
UnitedHealth said rising healthcare costs are forcing insurers to raise premiums and adjust benefits, which is contributing to membership losses in both ACA exchange plans and privately run Medicare Advantage plans. The company said revenue has remained stable because higher pricing is offsetting the decline in enrollment.
But DeVeydt said that dynamic "is not a good thing for the system long term."
UnitedHealthcare served 48.5 million people in the second quarter, down 525,000 from the previous quarter. DeVeydt attributed membership declines largely to affordability pressures driven by higher healthcare costs, forecasting a loss of roughly 500,000 ACA exchange members and 1.1 million Medicare Advantage members in 2026.
Insurers, particularly those that run Medicare Advantage plans, have been pinched by an influx of people seeking care they delayed post-pandemic and high-cost specialty drugs like GLP-1s, among other factors.
But UnitedHealth's medical benefit ratio — a measure of total medical expenses paid relative to premiums collected — came in at 86.7% for the second quarter. That's an improvement from the 89.4% reported in the year-earlier period. A lower ratio typically indicates that the company collected more in premiums than it paid out in benefits, resulting in higher profitability.
Analysts were expecting a ratio of 88.5% for the quarter, according to StreetAccount.
The results come about a year after UnitedHealth
revealed
it is facing Department of Justice investigations over its Medicare billing practices.
DeVeydt said the company has no updates but continues to be "supportive" of the probe.
Choose CNBC as your preferred source on Google and never miss a moment from the most trusted name in business news.
Subscribe to CNBC PRO
Subscribe to Investing Club
Licensing & Reprints
CNBC Councils
Join the CNBC Panel
Digital Products
News Releases
Closed Captioning
Corrections
About CNBC
Internships
Site Map
Careers
Help
Contact
News Tips
Got a confidential news tip? We want to hear from you.
Get In Touch
CNBC Newsletters
Sign up for free newsletters and get more CNBC delivered to your inbox
Sign Up Now
Get this delivered to your inbox, and more info about our products and services.
Advertise With Us
Please Contact Us
Ad Choices
Privacy Policy
Your Privacy Choices
CA Notice
Terms of Service
©
2026
Versant Media, LLC. All Rights Reserved. A Versant Media Company.
Data is a real-time snapshot *Data is delayed at least 15 minutes.
Global Business and Financial News, Stock Quotes, and Market Data
and Analysis.
Market Data Terms of Use and Disclaimers
Data also provided by
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。